Innovent Biologics

Innovent’s trial of picankibart for ulcerative colitis meets primary endpoint
Clinical Trials Arena
Thu, 10/17/24 - 09:36 am
Innovent Biologics
ulcerative colitis
picankibart
clinical trials
ESMO: Innovent links cytokine fusion protein to responses in colorectal cancer
Fierce Biotech
Wed, 09/18/24 - 01:38 pm
Innovent Biologics
cytokine fusion protein
colorectal cancer
clinical trials
Innovent’s Lilly-Partnered Type 2 Diabetes Drug Aces Phase III in China, Inches Closer to Approval
BioSpace
Mon, 07/22/24 - 06:50 pm
Innovent Biologics
mazdutide
obesity
China
Eli Lilly
Innovent Biologics Closes ADC-Focused Maryland Site, Lays Off Researchers
BioSpace
Tue, 03/12/24 - 11:13 am
Innovent Biologics
R&D
layoffs
Maryland
Innovent's Tepezza rival one step closer to Chinese approval after phase 3 eye disease win
Fierce Biotech
Tue, 02/20/24 - 05:51 pm
Innovent Biologics
thyroid eye disease
Tepezza
China
Amgen
IBI311
Obesity: Six trials to watch over the next 12 months
Clinical Trials Arena
Fri, 06/30/23 - 11:45 am
obesity
clinical trials
Novo Nordisk
Altimmune
Innovent Biologics
Pfizer
Shionogi
Tonix
semaglutide
oxytocin
permvidutide
mazdutide
danuglipron
Eli Lilly dumps Innovent's PD-1 after FDA rebuff, nixing high-profile Chinese cancer drug
Fierce Pharma
Thu, 12/1/22 - 07:03 pm
Eli Lilly
Innovent Biologics
Tyvyt
China
Innovent doses first patient in Phase I diabetic macular edema trial
Clinical Trials Arena
Mon, 08/8/22 - 09:51 am
Innovent Biologics
clinical trials
IBI324
diabetic macular edema
Innovent's phase 3 hits tee it up to challenge Amgen and Sanofi for Chinese PCSK9 market
Fierce Biotech
Thu, 02/17/22 - 10:56 am
Innovent Biologics
China
clinical trials
Amgen
Sanofi
FDA sends signal with tough questions of Lilly at cancer drug meeting
BioPharma Dive
Thu, 02/10/22 - 10:37 pm
Eli Lilly
Innovent Biologics
lung cancer
clinical trials
China
Innovent - Eli Lilly's Sintilimab Combo Shows Sustained Survival Benefit In Lung Cancer Patients
Benzinga
Fri, 08/6/21 - 11:16 am
Innovent Biologics
Eli Lilly
sintilimab
clinical trials
non-small cell lung cancer
Eli Lilly Strikes $1 Billion Deal with Innovent for Checkpoint Inhibitor
BioSpace
Tue, 08/18/20 - 11:00 pm
Eli Lilly
Innovent Biologics
China
immuno-oncology
WCLC: Lilly, Innovent tout Tyvyt front-line lung cancer win. Can it challenge Merck’s Keytruda?
Fierce Pharma
Sun, 08/9/20 - 11:14 pm
Eli Lilly
Innovent Biologics
China
non-small cell lung cancer
Tyvyt
Merck
Keytruda
Roche pens $2B biobucks pact with Innovent Biologics for bispecific and cell therapies
Fierce Biotech
Tue, 06/9/20 - 12:17 pm
Roche
Innovent Biologics
China
bispecific antibodies
cell therapy
Innovent and Coherus Strike Licensing Agreement for Avastin Biosimilar
BioSpace
Thu, 01/16/20 - 11:14 pm
China
Innovent Biologics
Coherus Biosciences
biosimilars
Avastin
Innovent, Incyte sign collaboration deal for three clinical-stage product candidates
Pharmaceutical Business Review
Mon, 12/17/18 - 09:02 am
Incyte
Innovent Biologics
pemigatinib
itacitinib
parsaclisib
Chi-Med, Innovent enter global cancer partnership
BioCentury
Sat, 12/1/18 - 12:01 pm
Chi Med
Innovent Biologics
China
solid tumors
Eli Lilly partner urges investors to look beyond biotech turmoil
Indianpolis Business Journal
Fri, 11/2/18 - 09:13 am
Innovent Biologics
Eli Lilly
China
biotech
Hong Kong IPO delivers $421M to Innovent — fourth listed biotech in six months
Endpoints
Wed, 10/24/18 - 10:12 am
Hong Kong
IPOs
biotech
Innovent Biologics
Innovent Biologics Plans Hong Kong IPO to Raise $423 Million, Despite Global Downturn
Biopharma Dive
Mon, 10/15/18 - 12:07 pm
IPOs
Innovent Biologics
Hong Kong

Pages